Back to results

Massachusetts Institute of Technology

Eliminating oxygen supply limitations for transplanted microencapsulated islets in the treatment of type 1 diabetes

Abstract

dc:description.abstract

Type I diabetes is a disease that results from a person's impaired ability to produce insulin, a protein that regulates the blood glucose concentration. Insulin is produced by [beta]-cells in the Islets of Langerhans, which are aggregates of cells averaging about 150 [mu]m in diameter and constituting about 1 to 2% of the pancreas volume. The efficacy of islet transplantation as a treatment for diabetes has been demonstrated in humans by the Edmonton Protocol, but obstacles remain for wide scale application. One major issue is that successful islet transplantation requires permanent use of multiple immunosuppressive agents. These agents may have serious side effects as well as a substantial financial burden. Microencapsulation is used for full or partial protection of transplanted islets from immune rejection. However, the microcapsule prevents islet revascularization and creates an additional mass transfer resistance for oxygen transport to islets. This reduced oxygen transfer can lead to a hypoxic core within the islet that results in tissue death and reduced function. We have studied two approaches to enhance microencapsulated islet survival and function by reducing oxygen transport limitations. The first method involves incorporating a perfluorocarbon emulsion into alginate microcapsules to enhance oxygen permeability in order to protect islets from hypoxia. The second method involves dispersing the islets into single cells and allowing them to reaggregate into cell clusters smaller than the original islet. The smaller aggregates are less prone to the development of a necrotic core and can function normally because of adequate oxygen supply and the presence of cell to cell contacts.

Degree

thesis:*
Department dc:contributor.department
Massachusetts Institute of Technology. Dept. of Chemical Engineering.
Grantor dc:publisher
Massachusetts Institute of Technology
Year dc:date.issued
2008

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Lewis, Amy Suzanne
Advisor dc:contributor.advisor
  • Clark K. Colton.

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.
Language dc:language.iso
eng

Identifiers

dc:identifier.*
Handle dc:identifier.uri
http://hdl.handle.net/1721.1/42941
OAI identifier oai:identifier
oai:dspace.mit.edu:1721.1/42941

Chain of custody

source
Harvested from
MIT
Base URL
dspace.mit.edu/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
citation

Lewis, Amy Suzanne. Eliminating oxygen supply limitations for transplanted microencapsulated islets in the treatment of type 1 diabetes. Massachusetts Institute of Technology, 2008. http://hdl.handle.net/1721.1/42941